GlassScriptPhysician profile
Elise B Rogers
NPI 1104367531
$2,588.99
in general payments reported to CMS, 2019-2025
32 companies · $70.26 in 2025
The $70.26 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $788 · 2023: $570 · 2024: $934 · 2025: $70.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $488.92 | 2022-2023 | |
| Abbvie INC. | $206.81 | 2021-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $202.19 | 2024-2025 | Veozah |
| Myovant Sciences INC. | $196.47 | 2021-2022 | |
| Coopersurgical, INC. | $159.70 | 2022-2024 | Advincula Delineator Uterine Manipulator, Wallach Cryosurgical Equipment, Paragard T 380a |
| Sumitomo Pharma America, INC. | $150.51 | 2023-2024 | Myfembree, Gemtesa |
| Organon LLC | $113.86 | 2022-2024 | Nexplanon |
| Axonics, INC. | $112.91 | 2023-2024 | Axonics |
| Pfizer INC. | $88.88 | 2022-2024 | |
| Medtronic, INC. | $86.08 | 2022-2025 | Plasmablade(Tm) |
| Caldera Medical, INC | $79.78 | 2023 | Desara |
| Exeltis, USA INC. | $79.09 | 2022-2024 | Slynd |
| Evofem Biosciences, INC. | $71.79 | 2022-2024 | |
| Smith+Nephew, INC. | $57.46 | 2022-2024 | Pico 7 |
| Bayer Healthcare Pharmaceuticals INC. | $57.19 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $47.95 | 2024 | |
| Biogen, INC. | $46.81 | 2024 | |
| Idorsia Pharmaceuticals US INC | $43.95 | 2022-2023 | Quviviq |
| Avion Pharmaceuticals | $32.28 | 2023 | Balcoltra |
| Shield Therapeutics INC | $24.37 | 2024 | |
| Hologic Sales and Service, LLC | $23.91 | 2024 | Aptima |
| Dexcom, INC. | $23.68 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $23.26 | 2024 | Stratafix, Ethicon, Dermabond Prineo |
| Integra Lifesciences Corporation | $22.83 | 2022 | |
| Merck Sharp & Dohme LLC | $22.33 | 2022 | |
| Daiichi Sankyo INC. | $21.21 | 2022 | |
| Agile Therapeutics, INC. | $20.35 | 2023 | Twirla |
| Aspira Women'S Health INC | $17.99 | 2024 | Ova1 |
| Biotissue Holdings INC. | $17.77 | 2024 | |
| Dilon Technologies, INC. | $17.65 | 2023 | Hemoblast Bellows |
| Millicent US INC | $15.87 | 2024 | Femring, Intrarosa |
| Convatec INC. | $15.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.